Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Glioblastoma × perampanel × 30 days × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Temozolomide 22 Magnetic Resonance Spectroscopy 13 Radiotherapy 12 Specimen Handling 8 Radiation 5 pembrolizumab 4 Nivolumab 4 Ipilimumab 3 Cyclophosphamide 3 Biopsy 3 Bevacizumab 3 Aminolevulinic Acid 3 olaparib 2 fludarabine 2 cemiplimab 2 abemaciclib 2 Surgical Procedures, Operative 2 Receptors, Interleukin-8B 2 Lomustine 2 veliparib 1 trastuzumab deruxtecan 1 trametinib 1 senicapoc 1 selinexor 1 sargramostim 1 ruxolitinib 1 rocakinogene sifuplasmid 1 ribociclib 1 relatlimab 1 regorafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07284069 2026-03-04

SENIPERA

University of Aarhus

Phase EARLY_PHASE1 Recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡